Bingham Osborn & Scarborough LLC Boosts Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Bingham Osborn & Scarborough LLC raised its position in UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 1,455 shares of the healthcare conglomerate’s stock after buying an additional 172 shares during the period. Bingham Osborn & Scarborough LLC’s holdings in UnitedHealth Group were worth $541,000 at the end of the most recent quarter.

A number of other large investors have also recently bought and sold shares of UNH. The Manufacturers Life Insurance Company lifted its position in shares of UnitedHealth Group by 0.7% during the first quarter. The Manufacturers Life Insurance Company now owns 3,623,499 shares of the healthcare conglomerate’s stock worth $1,348,195,000 after purchasing an additional 26,846 shares during the last quarter. TCTC Holdings LLC lifted its position in shares of UnitedHealth Group by 10.5% during the fourth quarter. TCTC Holdings LLC now owns 13,700 shares of the healthcare conglomerate’s stock worth $4,805,000 after purchasing an additional 1,303 shares during the last quarter. AGF Investments Inc. raised its stake in UnitedHealth Group by 18.7% during the fourth quarter. AGF Investments Inc. now owns 518,475 shares of the healthcare conglomerate’s stock worth $181,819,000 after acquiring an additional 81,789 shares during the period. Calamos Wealth Management LLC raised its stake in UnitedHealth Group by 3.2% during the first quarter. Calamos Wealth Management LLC now owns 39,271 shares of the healthcare conglomerate’s stock worth $14,612,000 after acquiring an additional 1,207 shares during the period. Finally, Trust Asset Management LLC raised its stake in UnitedHealth Group by 30.3% during the fourth quarter. Trust Asset Management LLC now owns 6,268 shares of the healthcare conglomerate’s stock worth $2,198,000 after acquiring an additional 1,458 shares during the period. 86.03% of the stock is owned by institutional investors.

In related news, Director Richard T. Burke sold 4,000 shares of the firm’s stock in a transaction that occurred on Monday, March 15th. The shares were sold at an average price of $353.32, for a total value of $1,413,280.00. Following the completion of the transaction, the director now owns 153,953 shares of the company’s stock, valued at approximately $54,394,673.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Patricia L. Lewis sold 3,000 shares of the firm’s stock in a transaction that occurred on Friday, April 16th. The stock was sold at an average price of $389.99, for a total transaction of $1,169,970.00. Following the completion of the transaction, the executive vice president now directly owns 9,214 shares of the company’s stock, valued at approximately $3,593,367.86. The disclosure for this sale can be found here. Insiders have sold 14,801 shares of company stock valued at $5,653,468 over the last 90 days. 0.80% of the stock is currently owned by insiders.

Shares of NYSE:UNH opened at $409.80 on Friday. The stock has a market capitalization of $386.73 billion, a price-to-earnings ratio of 23.54, a PEG ratio of 1.55 and a beta of 0.74. UnitedHealth Group Incorporated has a 1-year low of $273.71 and a 1-year high of $425.98. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.82 and a current ratio of 0.82. The company has a 50 day moving average price of $389.73 and a 200 day moving average price of $353.97.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Wednesday, April 14th. The healthcare conglomerate reported $5.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $4.38 by $0.93. The firm had revenue of $70.20 billion during the quarter, compared to analysts’ expectations of $69.13 billion. UnitedHealth Group had a net margin of 6.62% and a return on equity of 27.53%. The firm’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same period last year, the firm posted $3.72 earnings per share. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 16.75 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which was paid on Tuesday, March 23rd. Investors of record on Monday, March 15th were issued a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 1.22%. The ex-dividend date was Friday, March 12th. UnitedHealth Group’s payout ratio is 33.09%.

Several equities research analysts recently weighed in on the stock. Barclays increased their price objective on shares of UnitedHealth Group from $405.00 to $435.00 and gave the stock an “overweight” rating in a research note on Thursday, April 22nd. Morgan Stanley increased their price objective on shares of UnitedHealth Group from $462.00 to $515.00 and gave the stock an “overweight” rating in a research note on Thursday, April 22nd. Credit Suisse Group raised their price target on shares of UnitedHealth Group from $415.00 to $430.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Truist Securities raised their price target on shares of UnitedHealth Group from $420.00 to $450.00 and gave the company a “buy” rating in a research note on Tuesday, April 20th. Finally, Oppenheimer raised their price target on shares of UnitedHealth Group from $375.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, April 22nd. Three research analysts have rated the stock with a hold rating, seventeen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $412.26.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance program, and health care programs; medical and dental benefits; and hospital and clinical services.

Read More: What is a put option?

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.